Gloucester Event Medics 05061956 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is Medical practice activities Digita Accounts Production Advanced 6.30.9574.0 true true 05061956 2024-04-01 2025-03-31 05061956 2025-03-31 05061956 core:CurrentFinancialInstruments 2025-03-31 05061956 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 05061956 core:Non-currentFinancialInstruments 2025-03-31 05061956 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 05061956 core:FurnitureFittingsToolsEquipment 2025-03-31 05061956 core:MotorVehicles 2025-03-31 05061956 core:OtherPropertyPlantEquipment 2025-03-31 05061956 bus:SmallEntities 2024-04-01 2025-03-31 05061956 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 05061956 bus:FilletedAccounts 2024-04-01 2025-03-31 05061956 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 05061956 bus:RegisteredOffice 2024-04-01 2025-03-31 05061956 bus:Director1 2024-04-01 2025-03-31 05061956 bus:Director2 2024-04-01 2025-03-31 05061956 bus:CompanyLimitedByGuarantee 2024-04-01 2025-03-31 05061956 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 05061956 core:MotorVehicles 2024-04-01 2025-03-31 05061956 core:OfficeEquipment 2024-04-01 2025-03-31 05061956 core:OtherPropertyPlantEquipment 2024-04-01 2025-03-31 05061956 core:PlantMachinery 2024-04-01 2025-03-31 05061956 countries:AllCountries 2024-04-01 2025-03-31 05061956 2024-03-31 05061956 core:FurnitureFittingsToolsEquipment 2024-03-31 05061956 core:MotorVehicles 2024-03-31 05061956 core:OtherPropertyPlantEquipment 2024-03-31 05061956 2023-04-01 2024-03-31 05061956 2024-03-31 05061956 core:CurrentFinancialInstruments 2024-03-31 05061956 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 05061956 core:Non-currentFinancialInstruments 2024-03-31 05061956 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 05061956 core:FurnitureFittingsToolsEquipment 2024-03-31 05061956 core:MotorVehicles 2024-03-31 05061956 core:OtherPropertyPlantEquipment 2024-03-31 iso4217:GBP xbrli:pure

FINANCIAL PERIOD DATA REFRESH REQUIRED
Select the Refresh button on the Summary or Disclosure tab

Registration number: 05061956

Gloucester Event Medics

trading as Gloucester Event Medics Ltd

(A company limited by guarantee)

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2025

 

Gloucester Event Medics

trading as Gloucester Event Medics Ltd

Contents

Company Information

1

Statement of Directors' Responsibilities

2

Balance Sheet

3

Notes to the Unaudited Financial Statements

4 to 8

 

Gloucester Event Medics

trading as Gloucester Event Medics Ltd

Company Information

Directors

Mr Stephen Price

Mr Mark Barnard

Registered office

15 Westgate House
Westgate Street
Gloucester
Gloucestershire
GL1 2RU

Accountants

Cashtrac Ltd
15 Westgate House
Westgate Street
Gloucester
Gloucestershire
GL1 2RU

 

Gloucester Event Medics

trading as Gloucester Event Medics Ltd

Statement of Directors' Responsibilities

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006 and in accordance with FRS 102 section 1A, the Financial Reporting Standard applicable to the Small Entities Regime. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

Gloucester Event Medics

trading as Gloucester Event Medics Ltd

(Registration number: 05061956)
Balance Sheet as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

23,131

22,487

Current assets

 

Cash at bank and in hand

 

1,030

1,065

Creditors: Amounts falling due within one year

5

(115,666)

(94,963)

Net current liabilities

 

(114,636)

(93,898)

Total assets less current liabilities

 

(91,505)

(71,411)

Creditors: Amounts falling due after more than one year

5

(54,714)

(50,618)

Net liabilities

 

(146,219)

(122,029)

Reserves

 

Other reserves

16,000

16,000

Retained earnings

(162,219)

(138,029)

Deficit

 

(146,219)

(122,029)

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 23 December 2025 and signed on its behalf by:
 

.........................................
Mr Stephen Price
Director

 

Gloucester Event Medics

trading as Gloucester Event Medics Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1

General information

The company is a company limited by guarantee, incorporated in England & Wales, and consequently does not have share capital. Each of the members is liable to contribute an amount not exceeding £1 towards the assets of the company in the event of liquidation.

The address of its registered office is:
15 Westgate House
Westgate Street
Gloucester
Gloucestershire
GL1 2RU
United Kingdom

The principal place of business is:
57 Lower Meadow
Quedegeley
Gloucester
Gloucestershire
GL2 4XN
England

These financial statements were authorised for issue by the Board on 23 December 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

 

Gloucester Event Medics

trading as Gloucester Event Medics Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant & Machinery

33% reducing balance

Motor Vehicles

25% reducing balance

Office Equipment

25% reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

 

Gloucester Event Medics

trading as Gloucester Event Medics Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 1 (2024 - 1).

 

Gloucester Event Medics

trading as Gloucester Event Medics Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

4

Tangible assets

Furniture, fittings and equipment
 £

Motor vehicles
 £

Other property, plant and equipment
 £

Total
£

Cost or valuation

At 1 April 2024

4,566

32,454

36,138

73,158

Additions

-

7,750

-

7,750

At 31 March 2025

4,566

40,204

36,138

80,908

Depreciation

At 1 April 2024

3,838

14,605

32,228

50,671

Charge for the year

182

5,634

1,290

7,106

At 31 March 2025

4,020

20,239

33,518

57,777

Net book value

At 31 March 2025

546

19,965

2,620

23,131

At 31 March 2024

728

17,849

3,910

22,487

5

Creditors

Creditors: amounts falling due within one year

Note

2025
£

2024
£

Due within one year

 

Loans and borrowings

6

406

-

Accruals and deferred income

 

2,988

1,488

Other creditors

 

112,272

93,475

 

115,666

94,963

Creditors: amounts falling due after more than one year

Note

2025
£

2024
£

Due after one year

 

Loans and borrowings

6

54,714

50,618

 

Gloucester Event Medics

trading as Gloucester Event Medics Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

6

Loans and borrowings

Non-current loans and borrowings

2025
£

2024
£

Other borrowings

54,714

50,618

Current loans and borrowings

2025
£

2024
£

Bank overdrafts

406

-

Other borrowings

The carrying amount of Directors Contributions at year end is £166,698 (2024 - £144,094).